Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Ding

Showing results (1011-1020 of 1,130) with videos related to

Pageof 113
Sort By:
JCI Insight|August 30, 2022
ISG20L2 suppresses bortezomib antimyeloma activity by attenuating bortezomib binding to PSMB5Yan Yang, Yuhan Gao, Jingcao Huang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 13, 2007
Impact of glucose-dependent insulinotropic peptide on age-induced bone lossKe-Hong Ding, Xing-Ming Shi, Qing Zhong, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 22, 2022
Estrogen-Responsive Gene MAST4 Regulates Myeloma Bone DiseaseYushan Cui, Fangfang Wang, Danfeng Zhang, et al.
Oncogenesis|November 3, 2018
Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinomaWei Chen, Hao Zhang, Zhifeng Chen, et al.
Acta Pharmacologica Sinica|May 26, 2018
Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assayTian Lu, Jun-Chi Hu, Wen-Chao Lu, et al.
Journal of Neurochemistry|February 18, 2015
Regulation of RAGE splicing by hnRNP A1 and Tra2β-1 and its potential role in AD pathogenesisXiao-Yan Liu, Hong-Lei Li, Jia-Bin Su, et al.
Molecular Cancer|February 23, 2018
The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1Chen-Hong Ding, Chuan Yin, Shi-Jie Chen, et al.
Bioorganic & Medicinal Chemistry|November 21, 2021
Design, synthesis and biological evaluation of a novel spiro oxazolidinedione as potent p300/CBP HAT inhibitor for the treatment of ovarian cancerHong Ding, Yuan Pei, Yuanqing Li, et al.
Insights Into Imaging|November 1, 2025
Ultrasound-derived fat fraction for the noninvasive quantification of hepatic steatosis: a prospective multicenter studyLiyun Xue, Yuli Zhu, Guangwen Cheng, et al.
Organic & Biomolecular Chemistry|November 1, 2017
Discovery of novel BET inhibitors by drug repurposing of nitroxoline and its analoguesHao Jiang, Jing Xing, Chen Wang, et al.
Pageof 113

Showing results (1011-1020 of 1,130) with videos related to

Sort By:
Pageof 113
JCI Insight|August 30, 2022
ISG20L2 suppresses bortezomib antimyeloma activity by attenuating bortezomib binding to PSMB5Yan Yang, Yuhan Gao, Jingcao Huang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 13, 2007
Impact of glucose-dependent insulinotropic peptide on age-induced bone lossKe-Hong Ding, Xing-Ming Shi, Qing Zhong, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 22, 2022
Estrogen-Responsive Gene MAST4 Regulates Myeloma Bone DiseaseYushan Cui, Fangfang Wang, Danfeng Zhang, et al.
Oncogenesis|November 3, 2018
Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinomaWei Chen, Hao Zhang, Zhifeng Chen, et al.
Acta Pharmacologica Sinica|May 26, 2018
Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assayTian Lu, Jun-Chi Hu, Wen-Chao Lu, et al.
Journal of Neurochemistry|February 18, 2015
Regulation of RAGE splicing by hnRNP A1 and Tra2β-1 and its potential role in AD pathogenesisXiao-Yan Liu, Hong-Lei Li, Jia-Bin Su, et al.
Molecular Cancer|February 23, 2018
The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1Chen-Hong Ding, Chuan Yin, Shi-Jie Chen, et al.
Bioorganic & Medicinal Chemistry|November 21, 2021
Design, synthesis and biological evaluation of a novel spiro oxazolidinedione as potent p300/CBP HAT inhibitor for the treatment of ovarian cancerHong Ding, Yuan Pei, Yuanqing Li, et al.
Insights Into Imaging|November 1, 2025
Ultrasound-derived fat fraction for the noninvasive quantification of hepatic steatosis: a prospective multicenter studyLiyun Xue, Yuli Zhu, Guangwen Cheng, et al.
Organic & Biomolecular Chemistry|November 1, 2017
Discovery of novel BET inhibitors by drug repurposing of nitroxoline and its analoguesHao Jiang, Jing Xing, Chen Wang, et al.
Pageof 113